WHOCC
Postal address:
Norwegian Institute of Public Health
WHO Collaborating Centre for Drug Statistics Methodology
Postboks 222 Skøyen
0213 Oslo
Norway

Visiting/delivery address:
Myrens verksted 6H
0473 Oslo
Norway

Tel:  +47 21 07 81 60
E-mail:
 
Copyright/Disclaimer

New search    Hide text from Guidelines

P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS

The group is subdivided according to types of parasites.


P01 ANTIPROTOZOALS
P01C AGENTS AGAINST LEISHMANIASIS AND TRYPANOSOMIASIS

P01CA Nitroimidazole derivatives

Nitroimidazole derivatives used for trypanosomiasis are classified in this group. Other nitroimidazole derivatives, see P01AB.

The DDD for benznidazole is based on the treatment of trypanosomiasis.
The DDD for fexinidazole is based on the average daily dose for the total 10 days course.

P01CB Antimony compounds

The DDDs are expressed as pentavalent antimony (Sb5+) used in the treatment of visceral leishmaniasis.

P01CC Nitrofuran derivatives

The DDDs are based on the treatment of trypanosomiasis.

P01CD Arsenic compounds

The DDDs are based on the treatment of trypanosomiasis.

P01CX Other agents against leishmaniasis and trypanosomiasis

This group comprises agents, which cannot be classified in the preceding groups.

The DDD for pentamidine isethionate is based on amount given per injection. The DDD for suramin sodium is based on the average daily dose for the treatment period.

Last updated: 2024-01-26